Teva Pharmaceutical (TEVA)

Teva Pharmaceutical (TEVA) Financial Statements


Teva Pharmaceutical Financial Overview

Teva Pharmaceutical's market cap is currently ―. The company's EPS TTM is $-1.982; its P/E ratio is -4.96; Teva Pharmaceutical is scheduled to report earnings on February 7, 2024, and the estimated EPS forecast is $0.75. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 3.85B$ 3.88B$ 3.66B$ 3.88B$ 3.60B
Gross Profit$ 1.85B$ 1.80B$ 1.58B$ 1.77B$ 1.67B
EBIT$ 75.00M$ -914.00M$ 2.00M$ -855.00M$ 418.00M
EBITDA$ 358.00M$ -614.00M$ 306.00M$ -549.00M$ 739.00M
Net Income Common Stockholders$ 894.00M$ -863.00M$ -207.00M$ -1.22B$ 56.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.25B$ 2.67B$ 2.14B$ 2.80B$ 2.23B
Total Assets$ 42.09B$ 43.09B$ 43.46B$ 44.01B$ 44.25B
Total Debt$ 20.30B$ 21.02B$ 21.04B$ 21.56B$ 21.62B
Net Debt$ 18.05B$ 18.35B$ 18.89B$ 18.76B$ 19.39B
Total Liabilities$ 34.58B$ 31.95B$ 34.84B$ 35.31B$ 34.73B
Stockholders Equity$ 6.93B$ 10.48B$ 7.86B$ 7.90B$ 8.77B
Cash Flow-
Free Cash Flow$ -144.00M$ 205.00M$ -284.00M$ 831.00M$ 421.00M
Operating Cash Flow$ 5.00M$ 324.00M$ -145.00M$ 973.00M$ 543.00M
Investing Cash Flow$ 184.00M$ 302.00M$ 181.00M$ 168.00M$ 147.00M
Financing Cash Flow$ -576.00M$ -55.00M$ -706.00M$ -711.00M$ -440.00M
Currency in USD

Teva Pharmaceutical Earnings and Revenue History

Teva Pharmaceutical Debt to Assets

Teva Pharmaceutical Cash Flow

Teva Pharmaceutical Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis